“…Among the 257 AMC-resistant E. coli, all 5 isolates (1.9%) resistant to amikacin contained the aac(6 )-Ib gene. Although it has been described that the aac(6 )-Ib gene confers resistance to amikacin, kanamycin, tobramycin and netilmicin [7], when applying EUCAST (2) To (2) K, To (2) Gm (1) To (1) K (1) Susceptible (1) aph (3 )-Ia 21 (20.0) K, Nm As expected (20) As expected (20) Gm, K, Nm (1) Gm, K (1) aac(3)-IIa 9 (8.6) Gm, Nt, To As expected (8) As expected (2) Gm, K, Nt, To (1) Gm, To (2) Gm (5) aac (6 )-Ib, aac(3)-IIa 8 (7.6) Ak, Gm, K, Nt, To As expected (1) As expected (1) Gm, K, Nt, To (7) Gm, K, Nt, To (2) Gm, K, To (4) Gm, To (1) aac (3) breakpoints only 4 of the 25 isolates (16%) containing only the aac(6 )-Ib gene presented this specific pattern, whilst the remaining 21 isolates were resistant to one or more of gentamicin, tobramycin, netilmicin or kanamycin, but not to amikacin. Using breakpoints established by the CLSI, none of isolates carrying the aac(6 )-Ib gene had the expected resistance phenotype to aminoglycosides; in fact, this gene was detected in one strain susceptible to all tested aminoglycosides ( Table 2).…”